News & Views

  • Access Agreement Could Benefit Clinicians and Patients

Access Agreement Could Benefit Clinicians and Patients

Feb 03 2019 Read 497 Times

Diagnostics solution provider Arcis Biotechnology has signed a technology access agreement allowing Teflex Inc access to its advanced nucleic acid sample preparation chemistry. The New York-based company will harness the tecnology in the development of a novel technology, which it believes will be disruptive and is intended to empower clinicians and drive better patient outcomes.

Offering the possibility of earlier diagnostics testing from a variety of sample types, the platform, which covers DNA and RNA extraction and preservation for downstream processing, was said to be supportive of both companies’ drive to improve diagnostic testing and benefit patients and healthcare professionals.

Peter Whitehurst, CEO, Arcis Biotechnology, commented: “We are delighted that Teleflex has chosen to leverage the speed and simplicity of our sample preparation technology in its product development programme. Obtaining genetic material from biological samples is a critical step in molecular biology processes and we are excited to see our platform being applied across many different and growing markets.”

The company recently announced a successful £1.25 million investment round and additional £0.5 million overfunding hosted by crowdfunding platform Capital Cell, following following its development successes in the isolation and preservation of microRNA (miRNA) and oncology biomarkers. Arcis is now looking to invest further in R&D and product development to drive international business expansion. The additional £0.5 million from the Capital Cell funding round will underpin the Company’s projected revenue growth and associated working capital requirements in the next two years.

Reader comments

Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.

Post a Comment

Digital Edition

Lab Asia April 2019

April 2019

In This Edition Articles - Mobile Affinity Sorbent Chromatography Of Proteins - Integration of MS and UV Data for Peak Tracking in HPLC Method Development - VMXm takes its First Users 'wher...

View all digital editions


Analitika Expo 2019

Apr 23 2019 Moscow, Russia


Apr 30 2019 Chicago, IL, USA

Making Pharmaceuticals Exhibition & Conference 2019

Apr 30 2019 Ricoh Arena, Coventry, UK

AOCS Annual Meeting & Expo

May 05 2019 St. Louis, MO, USA

ISCC & GCxGC 2019

May 13 2019 Fort Worth, Tx, USA

View all events